Inflammatory Cardiomyopathy (DCMi) - Pathogenesis and Therapy: Progress in Inflammation Research
Editat de Heinz-Peter Schultheiss, Michel Noutsiasen Limba Engleză Hardback – 22 iun 2010
Din seria Progress in Inflammation Research
- 5% Preț: 1404.03 lei
- 5% Preț: 708.44 lei
- 18% Preț: 930.96 lei
- 15% Preț: 635.31 lei
- 5% Preț: 1274.34 lei
- 5% Preț: 1081.59 lei
- 5% Preț: 1061.93 lei
- 5% Preț: 700.90 lei
- 5% Preț: 1076.37 lei
- 5% Preț: 644.63 lei
- 5% Preț: 703.43 lei
- 5% Preț: 996.71 lei
- 5% Preț: 1385.03 lei
- 5% Preț: 1080.12 lei
- 5% Preț: 1080.47 lei
- 5% Preț: 991.70 lei
- 5% Preț: 1093.24 lei
- 5% Preț: 705.74 lei
- 5% Preț: 1579.06 lei
- 5% Preț: 641.03 lei
- 5% Preț: 1385.95 lei
- 5% Preț: 639.61 lei
- 5% Preț: 1077.64 lei
- 5% Preț: 1818.92 lei
- 15% Preț: 631.92 lei
- 5% Preț: 1086.24 lei
- 5% Preț: 645.16 lei
- 5% Preț: 1086.05 lei
- 24% Preț: 801.38 lei
- 5% Preț: 700.73 lei
- 5% Preț: 1770.39 lei
- 5% Preț: 706.82 lei
- 5% Preț: 991.70 lei
- 5% Preț: 706.10 lei
- 5% Preț: 1077.79 lei
- 15% Preț: 566.19 lei
- 5% Preț: 639.61 lei
- 5% Preț: 640.15 lei
- 5% Preț: 637.12 lei
- 5% Preț: 1094.10 lei
- 5% Preț: 1074.75 lei
- 5% Preț: 1383.96 lei
- 5% Preț: 1391.67 lei
- 5% Preț: 707.16 lei
- 5% Preț: 1079.77 lei
- 5% Preț: 1076.92 lei
Preț: 1582.27 lei
Preț vechi: 1665.54 lei
-5% Nou
Puncte Express: 2373
Preț estimativ în valută:
302.84€ • 314.79$ • 250.86£
302.84€ • 314.79$ • 250.86£
Carte disponibilă
Livrare economică 15-29 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783764383510
ISBN-10: 3764383518
Pagini: 294
Ilustrații: 294 p.
Dimensiuni: 165 x 235 x 25 mm
Greutate: 0.82 kg
Ediția:2010
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Progress in Inflammation Research
Locul publicării:Basel, Switzerland
ISBN-10: 3764383518
Pagini: 294
Ilustrații: 294 p.
Dimensiuni: 165 x 235 x 25 mm
Greutate: 0.82 kg
Ediția:2010
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Progress in Inflammation Research
Locul publicării:Basel, Switzerland
Public țintă
ResearchCuprins
Myocarditis and inflammatory cardiomyopathy — clinical management, epidemiology and prognosis.- Pathogenesis, diagnosis and treatment of pericarditis.- Epidemiology and Prognosis of Myocarditis and dilated Cardiomyopathy: Predictive Value of Clinical Parameters and Biopsy Findings.- Animal models of myocarditis — autoimmunity and viral infection; therapeutic interventions.- Autoimmune Murine Myocarditis and Immunomodulatory Interventions.- Coxsackievirus-induced murine myocarditis and immunomodulatory interventions.- Myocardial Proteases and Matrix Remodeling in Acute Myocarditis and Inflammatory Cardiomyopathy.- Alterations of the immune system in human viral and inflammatory cardiomyopathy.- Molecular genetics of cardiomyopathies and myocarditis.- Pathogenic relevance of autoantibodies in dilated cardiomyopathy.- The role of cytokines in inflammation-induced cardiomyopathy: Pathogenesis and therapeutic implications.- Diagnosis of inflammatory and viral cardiomyopathy.- Histology and immunohistology of myocarditis.- Immunohistological diagnosis of inflammatory cardiomyopathy and diagnosis of cardiotropic viral infections.- Cardiac magnetic resonance imaging: A non-invasive approach for the detection of myocardial inflammation — Potentials and limitations.- Treatment strategies in inflammatory cardiomyopathy patients.- Clinical management of acute myocarditis and cardiomyopathy.- Immunosuppressive treatment of inflammatory cardiomyopathy patients.- Antiviral interferon-? treatment in patients with chronic viral cardiomyopathy.- Immunoadsorption in dilated cardiomyopathy patients.
Notă biografică
Cardiomyopathy is one of the most frequent causes of heart failure, and a leading entity of cardiac transplantation in the era of modern heart failure regimens. This volume focuses on major advances in inflammatory cardiomyopathy (DCMi) during the past 10 years.The book is divided up into the following sections: 1. Myocarditis and inflammatory cardiomyopathy – clinical management, epidemiology and prognosis; 2. Animal Models of myocarditis – autoimmunity and viral infection; therapeutic interventions; 3. Alterations of the immune system in human viral and inflammatory cardiomyopathy; 4. Diagnosis of inflammatory and viral cardiomyopathy; 5. Treatment strategies in inflammatory cardiomyopathy patients. An international group of authors discusses topics as the histological Dallas criteria for clinical diagnostics, emerging relevance of immunohistological detection of DCMi and detectability of viruses in EMBs, and epidemiology and standard clinical treatment of acute myocarditis and dilated cardiomyopathy patients.This volume serves as a valuable source for cardiologists and cardiovascular pathologists to update their knowledge on DCMi, a still enigmatic and fascinating cardiovascular disorder, which has made major steps from bench to bedside in the past decade.
Textul de pe ultima copertă
Cardiomyopathy is one of the most frequent causes of heart failure, and a leading entity of cardiac transplantation in the era of modern heart failure regimens. This volume focuses on major advances in inflammatory cardiomyopathy (DCMi) during the past 10 years.
The book is divided up into the following sections: 1. Myocarditis and inflammatory cardiomyopathy – clinical management, epidemiology and prognosis; 2. Animal Models of myocarditis – autoimmunity and viral infection and therapeutic interventions; 3. Alterations of the immune system in human viral and inflammatory cardiomyopathy; 4. Diagnostic concepts of inflammatory and viral cardiomyopathy in endomyocardial biopsies (EMBs) including cardiac magnetic resonance; 5. Conventional and immunomodulatory treatment strategies in inflammatory cardiomyopathy patients.
An international group of authors discusses topics as the histological Dallas criteria for clinical diagnostics, emerging relevance of immunohistological detection of DCMi and detectability of viruses in EMBs, and epidemiology and standard clinical treatment of acute myocarditis and dilated cardiomyopathy patients.
This volume serves as a valuable source for cardiologists and cardiovascular pathologists to update their knowledge on DCMi, a still enigmatic and fascinating cardiovascular disorder, which has made major steps from bench to bedside in the past decade.
The book is divided up into the following sections: 1. Myocarditis and inflammatory cardiomyopathy – clinical management, epidemiology and prognosis; 2. Animal Models of myocarditis – autoimmunity and viral infection and therapeutic interventions; 3. Alterations of the immune system in human viral and inflammatory cardiomyopathy; 4. Diagnostic concepts of inflammatory and viral cardiomyopathy in endomyocardial biopsies (EMBs) including cardiac magnetic resonance; 5. Conventional and immunomodulatory treatment strategies in inflammatory cardiomyopathy patients.
An international group of authors discusses topics as the histological Dallas criteria for clinical diagnostics, emerging relevance of immunohistological detection of DCMi and detectability of viruses in EMBs, and epidemiology and standard clinical treatment of acute myocarditis and dilated cardiomyopathy patients.
This volume serves as a valuable source for cardiologists and cardiovascular pathologists to update their knowledge on DCMi, a still enigmatic and fascinating cardiovascular disorder, which has made major steps from bench to bedside in the past decade.
Caracteristici
Comprehensive overview, covering epidemiology/prognosis, pathology, immunology, diagnosis and treatment strategies Prof. Schultheiss is a leading expert in this area